About the JCI
The Journal of Clinical Investigation is a top-tier venue for discoveries in basic and clinical biomedical research that will advance the practice of medicine. The JCI:
- has a 2012 Impact Factor of 12.812 and a 5-year Impact Factor of 14.689,
- provides free access to all of its research articles,
- deposits published research articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements, and
- is an ideal home for authors seeking the broadest audience for their most important work.
The journal is headed by Editor in Chief Dr. Howard Rockman and an Editorial Board of peer scientists at Duke University Medical Center, the University of North Carolina, Duke-NUS, and Sanford-Burnham Medical Research Institute whose depth and experience ensure fair and competent peer review.
Sending your work to the JCI
The journal considers research submissions in several categories. The JCI receives submissions only through its website; submissions by mail or e-mail will be returned. Most new and de novo resubmissions require a nonrefundable US$75 submission fee (payable by Visa, Mastercard, or American Express).
Do you have a question about a manuscript you've already submitted?
- When a manuscript is received and confirmed by the JCI, an acknowledgment is sent via e-mail to the corresponding author. For any communication with us, please reference the tracking number assigned by the JCI noted in the acknowledgment. If you do not know or are unsure about the tracking number, reference the manuscript title and corresponding author name. Send e-mail to email@example.com or call 734-222-6050.
- In order to avoid confusion regarding correspondence, inquiries, and decisions, the JCI will typically communicate only with those who are designated as corresponding authors during the submission process.